Bone Biologics Corporation
$5.70
-1.95 (-25.49%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -43.0%
- 3 Months
- -68.2%
- YTD
- -63.2%
- 1 Year
- -47.2%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 169.7%
- Largest decline max drawdown, since Aug 2025
- -90.3%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.49
Own BBLGW?
See how BBLGW contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.